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pace, forging unsuspected connections with human car-
diovascular physiology and disease. The translucent na-
ture of the organism has facilitated large scale mutagen-
esis screens for diverse cardiovascular phenotypes (for
a review, see Shin and Fishman, 2002), while the density
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2 Department of Molecular Biology of the zebrafish genetic map and ongoing genome proj-
The University of Texas Southwestern ect have led to an ability to clone the corresponding
Medical School genes within a relatively short time span (3–6 months).
Dallas, Texas 75390 The system appears to be particularly valuable for identi-
fying new genes and pathways in vasculogenesis. grid-
lock, a gene that encodes a member of the Hairy/“One country, two systems.”
—Deng Xiaoping, referring to the reunification of Hong Enhancer of Split family of related bHLH proteins, acts
Kong and China. as a molecular switch for the distinct identity of arteries
New York Times, January 2, 1985 and veins by repressing the venous cell fate in pre-angio-
blasts, which is thereby permissive for artery formation.
As noted by a former Chairman, the term “one country- The zebrafish mutant phenotype resembles aspects of
two systems” was initially coined to describe a new human aortic coarctation (Zhong et al., 2001). The ability
experimental paradigm for normalized relations be- of gridlock to govern the decision between arterial and
tween Hong Kong and China, two territories that had venous cell fates is a reflection of its activity as a tran-
long been united, but had evolved along separate paths scriptional target of the Notch signaling pathway, long
during the Twentieth Century. Over the past 50 years, known to dictate mutually exclusive cell fates in diverse
studies of the cardiovascular system have also evolved cell types. Surprisingly, knockout mice for the gridlock
along distinct pathways, largely based upon the territo- ortholog Hey2 do not show aortic coarctation, but fre-
rial boundaries of modern developmental biology and quently succumb to severe neonatal cardiomyopathy.
clinical physiology. The developmental viewpoint has A combined loss of Hey1 and Hey2, however, leads
been underpinned by genetics, and a reductionist ap- to vascular defects similar to gridlock, suggesting that
proach toward mechanism, with molecular biology as these genes have undergone partial sub- or neofunc-
its primary tool, and the smallest biological unit being tionalization during vertebrate evolution (M. Gessler,
individual cell types. The clinical cardiology viewpoint University of Wuerzburg).
has been based on physiology, and an integrative ap- Two new genes that lie in an identical pathway for the
proach toward mechanism, with interventional/device/ endothelial-myocardial driven cues for valvulogenesis
imaging technologies as the primary tools, and the (Walsh and Stainier, 2001) (D. Stainier, UCSF) were pre-
smallest biological unit being the intact organ. In short, sented, as well as a new transgenic strain harboring a
studies of the cardiovascular system have traditionally fli-1 GFP construct that allows in vivo visualization of
been approached by citizens of “two” very different sci- the entire vasculature. This strain should facilitate sub-
entific cultures and “countries,” each with their own sequent modifier screens utilizing existing mutants with
societies, uniforms, icons, and customs. If the recent interesting vascular phenotypes (Weinstein, NIH). In this
67th Quantitative Symposium of Cold Spring Harbor Lab- regard, over 700 mutants that affect discrete steps of
oratory on “The Cardiovascular System” is any guide, zebrafish vessel formation and/or maturation have been
this era of “one system-two countries” is coming to a isolated (H. Habeck, Exelixis, Germany). Mark Fishman
close. During this symposium, converging pathways and (MGH) presented an elegant case for the zebrafish as a
perspectives of cardiovascular development and physi- system to unravel the “logic” of disease pathogenesis.
ology were presented, driven by post-genomic tools and Toward this end, a compelling argument can be made
technology, a new generation of scientists and physi-
that a parallel effort on physiological characterization of
cians trained to work at the interface of developmental
this model organism is now warranted to allow direct
biology, genetics, physiology, and human disease, and
connections between novel genes and clinically relevantan integrative approach to biology. This review high-
functional endpoints. Clearly, studies in zebrafish arelights some of the central themes presented by dele-
demonstrating that the border between developmentalgates of both “countries” that provided new insights
biology and disease is dissolving as shared pathways forinto developmental principles of human cardiovascular
prenatal morphogenic steps and postnatal physiologicalphysiology and disease.
events continue to be uncovered.
Zebrafish Genetics: An Experimental System
Vascular Lineages and Therapeutic AngiogenesisLinking Cardiovascular Development
In 1994, the first report of therapeutic angiogenesisand Disease
based on the single administration of one angiogenicZebrafish genetics is beginning to uncover genes and
factor, VEGF, appeared (Takeshita et al., 1994). Thispathways for cardiac development at a breathtaking
result pointed to the promise of therapeutic angiogen-
esis as a new molecular therapy for chronic coronary3 Correspondence: kchien@ucsd.edu (K.R.C.); eric.olson@
utsouthwestern.edu (E.N.O) and peripheral arterial disease. Although therapeutic an-
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Figure 1. Multiple Lineages and Pathways
for Formation of the Heart Vasculature
(A) Migratory cell lineages of the heart vascu-
lature. A subpopulation of neural crest cell
lineages migrates to the cardiac region (blue),
and is required for the reorganization of the
outflow tract in the developing heart. Neural-
crest-derived cells surround the pharyngeal
arch arteries and populate the aorticopulmo-
nary septum and conotruncal cushion. A
patch of neural-crest derived cells is also
consistently observed in the ventricles of
mouse embryos. Their physiological signifi-
cance is currently unknown, but may be in-
volved with the development of the coronary
circulation. Coronary vasculogenesis de-
pends on a selected population of precursors
from the liver primordia, the pro-epicardial
organ (in red). Pro-epicardial cells migrate
onto the surface of the fetal heart at the region
of the atrioventricular groove; they migrate
ventrally and cephalically until they com-
pletely cover the heart. Coronary arteries and
veins are assembled from endothelial, coro-
nary vascular smooth muscle, and pericyte
precursor cells within the subepicardial
matrix.
(B) Molecular pathways for the formation of
the coronary vasculature. A GATA4/Fog2
pathway mediates the myocardial secretion
of FGF factors that stimulate the epicardium
to transform into mesenchyme, while TGF-
antagonizes this transition. Activated epicar-
dial derived mesenchymal cells (EDM) mi-
grate through the basement membrane (BM)
to the subepicardial membrane where signals
from endothelial (EN) cells and/or the myo-
cardium recruit EDM cells to form nascent
vessels. As the mesenchymal cells are incor-
porated into nascent vessels, they differenti-
ate into coronary vascular smooth muscle
cells (CVSMC), pericytes (Perif), and inter-
myocardial fibroblasts (Myof) (modified from
Morabito et al., 2002).
giogenesis continues to be a laudable goal, its experi- specific angiogenic programs that are based on tissue-
specific angiogenic factors, exemplified by EG-VEGF,mental validation remains an open question, and the
clinical efficacy of therapeutic angiogenesis remains un- an angiogenic factor that is expressed in steroidogenic
glands such as ovary, adrenal, and testes, and actsclear. If the recent papers presented at CSH are any
measure, it appears as if early studies examining the selectively on endothelial cells of such endocrine organs
through a distinct class of G-protein-coupled receptorrole of single angiogenic factors as therapeutic strate-
gies may have severely underestimated the biological pathways (N. Ferrara, Genentech) (LeCouter et al., 2001).
Accordingly, it may be over-simplistic to expect that thecomplexity of vasculogenesis. One of the obligatory trig-
gers for angiogenesis is VEGF, a factor that has been administration of a single gene would be sufficient to
promote therapeutic coronary or peripheral arteriogene-shown to be both necessary and sufficient for angiogen-
esis in vivo. However, recent studies of a host of addi- sis, without first identifying the unique combination of
core and tissue-specific angiogenic programs requiredtional angiogenic factors, including angiopoietins-1 and
-2 (Yancopoulos et al., 2000) (Regeneron), suggest that in the target organ of interest. This may be particularly
important for therapeutic coronary arteriogenesis, asadditional components may be required to form fully
mature vessels that contain pericytes, smooth muscle the formation of the coronary arterial system in the fetal
heart is now known to require concerted developmentalcells, and distinct endothelial subtypes. Further, VEGF
can specifically induce expression of the synergistic cues derived from four discrete lineages: endothelial,
myocardial, pro-epicardial, and neural crest lineagesfactor angiopoietin-2 in muscle cells by an intracellular
pathway, but not when administered exogenously. This (Figure 1). Growing muscular coronary arteries that are
built to withstand the intrinsic biomechanical stress ofsuggests that VEGF gene and protein delivery might
elicit different biological effects as therapeutic angio- each heartbeat may first require a better definition of
the developmental cues and secreted factors requiredgenesis strategies (H. Blau, Stanford).
Intriguingly, it now appears that there may be organ- for normal coronary arteriogenesis. The ability to isolate
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primed coronary arterial progenitor cells could represent The question arises as to whether the requirement for
a valid alternative strategy that could complement exist- TBX1 actually is localized within neural crest lineages
ing approaches, particularly if these can be effectively per se, or whether it reflects non-cell-autonomous ef-
isolated from adult stem cell populations, and the fac- fects. Surprisingly, a growing body of evidence now
tors that are required for their recruitment and self- supports the concept that the TBX1 requirement is lo-
renewal identified. cated outside of neural crest lineages. Thus, the cardiac
Direct validation of anti-angiogenic strategies as inde- morphogenic defects associated with DiGeorge syn-
pendent chemotherapeutic regimens for broad classes drome do not reflect a primary effect on neural crest
of human cancers has also been elusive. As judged by formation, proliferation, or survival, but rather result from
the recent data presented at CSH, there not only appear the loss of guidance cues from the pharyngeal endo-
to be distinct molecular pathways for vasculogenesis in derm that are required for neural crest migration into
specific organ systems, but the existence of multiple, the aortic arch region (A. Baldini, Baylor). This view has
parallel pathways for tumor angiogenesis (R. Hynes, been independently supported by studies of the regula-
MIT; R. Benezra, Sloan-Kettering), supporting the view tory programs that control TBX1 expression in the
that the elimination of a single angiogenic factor may mouse (D. Srivastava, UTSW). Fgf8 may mediate the
not independently lead to the loss of solid tissue tumors. Tbx1 non-cell-autonomous effects on neural crest cells,
Recent studies of spontaneous tumors suggest that tu- as heterozygous deletion of the Fgf8 gene enhances the
mors can escape the blockade in single pathways in part Tbx1 haploinsufficiency phenotype in mice (Vitelli et al.,
via selection for alternative pathways (Benezra, 2001). 2002), a point supported by two other independent labo-
It may become possible to tailor the anti-angiogenic ratories (Frank et al., 2002; Abu-Issa et al., 2002). This
strategy for specific tumor types based upon tissue and secondary TBX1 effect on neural crest migration might
tumor-specific angiogenic pathways, as well as the syn- imply that an additional “hit” within neural crest lineages
ergistic effects of current chemotherapeutic regimens. acts as a modifier to enhance the phenotype, which
In this regard, kinase inhibitor treatment of a genetically might reflect actions of other genes within or adjacent
engineered mouse model of pancreatic islet cancer im- to the DiGeorge minimal region. Interestingly, 90% of
plicated PDGF receptor signaling in tumor vessel-asso- individuals with neural crest-related defects display
ciated pericytes as crucial for maintenance and continu- hemizygous deletions of CDC 45, a cell cycle regulator
ing angiogenesis of tumor vasculature (Bergers, UCSF). which falls within the DiGeorge minimal region, although
Additional results from that model demonstrated the mice that are heterozygous for a CDC 45 null allele do
benefits of combinatorial anti-angiogenic therapies uti- not display cardiac defects (Yoshida et al., 2001). Ac-
lizing protease inhibitors and low dose, “metronomic” cordingly, it will be of interest to generate compound
chemotherapy (Bergers). mutant mice which harbor a complete deficiency of
TBX1 and partial deficiencies in other contiguous genes,
Neural Crest Lineages and Congenital Heart Disease such as CDC 45, that lie within the DiGeorge minimal
The clinical link between neural crest lineages and car- region. Such an approach has the potential to identify
diac development was established by the characteriza- key modifiers of cardiac congenital heart defects.
tion of children harboring a characteristic subset of con-
genital heart defects that were invariably accompanied
Renal Cell Lineages and Hypertension
by neural-crest-related defects. These children harbor
Hypertension is a complex trait that is influenced bymicrodeletions in chromosome 22 and a minimal region
multiple organs, including the brain, heart, kidney, adre-has been established by careful genotype-phenotype
nals, and vascular endothelium. Recent studies of rarecorrelations in large global patient populations. At-
forms of familial hypertension are beginning to reveal thetempts to refine the disease interval and to identify the
first genetic pathways for rare familial forms of humanspecific gene(s) responsible for the defects have been
hypertension. By collecting families from around theelusive at the clinical level, but recent studies in mice
globe which have severe, early onset hypertension, mu-have shown that a single gene, TBX 1, is likely to be the
tations in a number of new human hypertensive genesmost important gene within this region to account for a
including those encoding the epithelial sodium channelsubset of the neural crest-related cardiac congenital
(ENAC), the mineralocorticoid receptor, and a renal WNKdefects (Lindsay et al., 2001; Merscher et al., 2001; Je-
kinase have been identified (Lifton et al., 2001). Remark-rome and Papaioannou, 2001). However, to date, no
ably, in addition to these hypertensive genes, anotherpatients with TBX1 mutations have been found that dis-
set of human mutations has been found that lowersplay the full spectrum of cardiac neural crest defects,
blood pressure. All of these genes have their primarysuggesting that other genes in this minimal region may
effect in renal cell lineages, pointing to the central rolecontribute to the human phenotype. In this regard,
of the kidney in the onset of human hypertension. AsTBX1-deficient mice only display a subset of the neural
noted by Rick Lifton (Yale), while it is clear that bloodcrest defects found in DiGeorge children (aortic arch
pressure can be controlled by a number of differentanomalies), again providing support for DiGeorge as a
agents that work outside of these renal pathways, thecontiguous gene syndrome. Given the number of genes
question arises as to whether the design of specificin the minimal critical region of chromosome 22, and
antagonists to these specific renal targets might havethe existence of non-overlapping deletions that result
long-term beneficial effects that go beyond effects onin the same phenotype, it is likely that positional effects
the control of blood pressure per se, but extend toand long-range chromatin interactions contribute to the
chronic effects of hypertension on end-organ diseasesdifficulty in pin-pointing a single gene as the culprit in
all aspects of this disease. of the heart, brain, or the kidney itself. The recent unsus-
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pected major therapeutic benefit of mineralocorticoid of myocardin can prevent heart formation in frog em-
bryos. It will be of interest to identify additional cofactorsantagonists in heart failure raises interesting questions
about the potential role of this nuclear hormone receptor for myocardin and to investigate its potential roles in
cardiac gene expression during later stages of develop-in heart muscle cells. Accordingly, it will be interesting
to cross mice that harbor cardiac-restricted mutations ment and disease. In addition, the growing database of
putative cardiac transcriptional regulators suggests newof this gene into well-characterized mouse models of
cardiomyopathy and heart failure. In short, the discovery insights in the combinatorial pathways that control the
gene program may be on the horizon (J. Epstein, Univer-of these new pathways responsible for rare forms of
human hypertension is beginning to provide novel in- sity of Pennsylvania, and E. Olson, UTSW).
A zebrafish mutant, liebeskummer, with an excess ofsights and therapeutic targets for common forms of the
disease. The identification of a number of quantitative cardiomyocytes was also reported (M. Fishman, MGH).
The mutation was shown to activate reptin, an ATP-trait loci (QTLs) in spontaneous in-bred hypertensive
rat strains (Jacob and Kwitek, 2002), coupled with the dependent helicase that acts through an as yet unknown
mechanism to control growth of the ventricles. Ventricu-ongoing advances in the rat genome project, suggest
that additional insight into genetic pathways for the con- lar growth in the embryo is dependent on signals from
the overlying epicardium. Andrew Lassar (Harvard) pre-trol of hypertension will be forthcoming from experimen-
tal model systems, which should allow a direct compari- sented evidence that epicardial signaling requires Epo
and retinoic acid, which act through parallel pathwaysson in studies of more common forms of hypertension
in human populations. to stimulate myocardial growth by inducing a cardiac
myocyte mitogen in the epicardial cells. Neuregulin sig-
naling from the endocardium to the myocardium wasTranscriptional Control of Ventricular Growth
also shown by Richard Harvey (UNSW, AU) to play aand Development
critical role in embryonic growth and trabeculation ofSince the discovery of master regulators of skeletal mus-
the ventricular chambers.cle development, such as MyoD and myogenin, there
has been a push to identify corresponding regulators
of cardiac cell fate. Such factors would have obvious Signaling Pathways for Cardiac Hypertrophy
and Remodelingpotential in converting non-cardiac cells to the cardiac
lineage as an approach for repair and regeneration of The adult myocardium responds to extrinsic forms of
stress such as hypertension, myocardial infarction, andthe damaged adult myocardium. However, it appears
that forming a cardiac muscle cell is not so simple. While pressure-overload by a hypertrophic growth response
(for a review, see Chien, 1999). Inherited mutations inseveral cardiac-restricted transcription factors have
been identified, none have been found to possess the components of the sarcomere and cytoskeleton also
result in hypertrophic cardiomyopathy. Hypertrophy inability to confer cardiac identity on their own. However,
combinations of factors such as the zinc finger protein response to pathologic stimuli is accompanied by acti-
vation of a fetal gene program, which results in maladap-GATA4, the homodomain proteins Nkx2.5 and Tbx5 and
the MADS box protein serum response factor (SRF) are tive changes in contractility and calcium handling (Fig-
ure 2). Growth of the heart during normal postnatalable to activate some cardiac genes in transfected cells.
Tim Mohun (NIMR, UK) reported that ectopic expression development and in response to exercise also occurs
through hypertrophy. A key issue in the field is to deci-of GATA4 in injected frog animal caps was capable of
inducing the formation of beating cardiomyocytes. Simi- pher the pathways that control pathologic and physio-
logic hypertrophy, such that the former might be inhib-lar findings have been made with GATA5 in zebrafish
(D. Stainier, UCSF) (Reiter et al., 1999). Since these GATA ited and the latter augmented pharmacologically.
Changes in intracellular calcium handling have been im-factors are not restricted to the heart, and alone cannot
activate endogenous cardiac genes in transfection plicated as a trigger for cardiac hypertrophy, and numer-
ous calcium-dependent and calcium-independent (Gq,assays, they must act in conjunction with other tran-
scription factors and signaling systems in the context RAS, PI3K, p38) (for review, see Hoshijima and Chien,
2002) signaling systems have been shown to be neces-of the frog or fish embryo to initiate cardiogenesis in a
subset of cells. The concept that specific sets of extra- sary and sufficient to drive multiple features of cardiac
growth.cellular signals must be interpreted in a cell-specific
manner to generate the cardiac phenotype is consistent The notion that aberrant calcium handling plays a
central role in the hypertrophic program has been sup-with studies in Drosophila, in which overlapping gradi-
ents of cardiogenic signals act in conjunction with cell ported by several observations: (1) hypertrophic cardio-
myocytes exhibit alterations in calcium sensitivity andautonomous transcription factors to specify the identity
of cardiac cells (M. Frasch, Mt. Sinai). handling, some of which can be corrected by enhanced
activity of the SR Ca-ATPase through inhibition of itsSRF is required for the opposing processes of cell
proliferation and myogenesis. Myocardin, a novel car- inhibitor phospholamban (Minamisawa et al., 1999; Ho-
shijima et al., 2002); (2) numerous calcium-sensitive sig-diac-restricted transcription factor, has recently been
shown to stimulate transcription of SRF-dependent mus- naling pathways are activated in hypertrophic cardio-
myocytes (Molkentin et al., 1998) (for a review, see Freycle genes through its association with SRF (Wang et al.,
2001). Injection of myocardin mRNA into frog embryos et al., 2000); (3) forced activation of calcium-sensitive
signaling pathways is sufficient to induce myocyte hy-was reported to be sufficient to induce ectopic cardiac
gene expression (E. Olson, UTSW, and P. Krieg, Univer- pertrophy in vivo and in vitro (for review, see Leinwand,
2001). Thus, it is reasonable to assume that calciumsity of Arizona). Conversely, dominant negative mutants
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Figure 2. Cellular Pathways for Cardiac De-
velopment and Remodeling
Cytokines may attract circulating hemoto-
poietic stem cells to sites of cardiac injury.
These cells then adopt a cardiac fate through
mechanisms that remain unclear. During de-
velopment, the epicardium provides cues for
cardiac precursor proliferation. Cardiomyo-
cytes withdraw irreversibly from the cell cycle
after birth, but adult myocardial cells can re-
spond to stress signals to enter the program
for pathological hypertrophy or can respond
to normal growth signals for physiological hy-
pertrophy.
signaling plays a key role in many forms of hypertrophy, a transgenic mouse line that harbors a lacZ reporter
under control of MEF2 binding sites (Naya et al., 1999).but several other calcium-independent pathways are
also likely to mediate key aspects of the hypertrophic Using this mouse, Olson and coworkers showed that
the transcriptional activity of MEF2 is activated throughresponse, as well (for a review, see Sugden, 2001).
The involvement of calcium in hypertrophic signaling a post-translational mechanism in response to hypertro-
phic signals. Activation of MEF2 appears to be mediatedraises many obvious questions. For example, where does
the calcium come from? Given the extreme fluctuations by the signal-dependent dissociation of class II histone
deacetylases (HDACs), which are normally tethered toin intracellular calcium levels that accompany each cy-
cle of contraction and relaxation, is there a specific pool MEF2, resulting in repression of MEF2 target genes
(McKinsey et al., 2000). Stress signals lead to the phos-that controls hypertrophy? If so, how is it compartmen-
talized or insulated from other calcium in the sar- phorylation of HDACs by an as yet unidentified kinase.
Consistent with this model, signal-resistant mutants ofcoplasm? While calcineurin, CaMK, and MAPK have
each been shown to be sufficient, and in some cases HDACs act as irreversible repressors of hypertrophy,
and HDAC knockout mice are sensitized to hypertrophicnecessary, for hypertrophy, each of these enzymes is
activated by different concentrations and waveforms of signals.
By studying the effects of exercise on expression ofcalcium. Do each of these calcium-sensitive effectors
get activated by different hypertrophic signals? How are the MEF2-lacZ transgene, Leslie Leinwand (University
of Colorado) found that physiologic signals do not stimu-hypertrophic signaling pathways interconnected, and
how do they intersect with the calcium cycling ma- late MEF2 activity in the heart. Intriguingly, cardiac MEF2
activity is dramatically induced in male, but not female,chinery?
Mice engineered to express a mutant form of -MHC mice that misexpress mutant MHC. Paradoxically, re-
moval of estrogens from the diet restores cardiac func-with a codon 403 mutation that mimics a common hu-
man mutation develop hypertrophic cardiomyopathy tion in these male mice. These findings suggest that
MEF2 is a specific endpoint for pathologic stimuli thatand exhibit abnormal calcium homeostasis, such that
the mutant sarcomere requires a greater amount of cal- lead to hypertrophy, and that there is a gender-specific
influence on this stress-response pathway. Thus, ap-cium than the wild-type sarcomere to generate the same
level of force (Fatkin et al., 2000). SR calcium levels proaches that specifically interfere with upstream sig-
naling pathways that lead to MEF2 activation might haveare also reduced in these mutants, suggesting that the
mutant sarcomere sequesters a higher level of calcium clinical benefit as anti-hypertrophic agents.
than wild-type, with resulting perturbation in intracellular
calcium homeostasis. This notion is supported by the Mechanical Signaling
In addition to these recent advances in dissecting thefinding that the L-type calcium channel blocker diltiazem
restores SR calcium levels and normal contractility and signaling cascades and transcriptional mediators of hy-
pertrophy, genomic databases are also uncovering aprevents hypertrophy in the mutant heart. Jon Seidman
(Harvard) presented evidence suggesting that sarco- growing number of novel cytoskeletal genes whose
products play pivotal roles in mechanosignaling andmere mutations may activate different hypertrophic sig-
naling pathways from pressure overload. However, the stress-responsiveness (for a review see Chien, 2000;
Clarke et al., 2002). An expanding number of these novel,molecular mechanisms whereby sarcomere mutations
result in hypertrophic cardiomyopathy remain unknown. muscle-specific cytoskeletal components are localized
in the cardiac Z disc, thereby implying that the Z discAnother major question in the field is to determine
how hypertrophic signals are transmitted to the nucleus, may play a specialized function beyond a purely struc-
tural role (Figure 3). At the Z disc, -actinins are orga-with resulting reprogramming of cardiac gene expres-
sion. The MEF2 transcription factor appears to be a nized into a series of anti-parallel dimers, which cross-
link polymerized actin filaments (thin filaments). The Zcritical target for hypertrophic signals, as revealed with
Cell
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Figure 3. Cytoskeletal Proteins Localized in
the Cardiac Z Disc
-actinin is a major cross-linking component
of actin at the Z disc and the C-terminal do-
main of titin is anchored at the Z disc. Several
muscle-restricted LIM domain proteins are
also localized to this region. MLP, muscle-
specific LIM protein; ALP, -actinin associ-
ated LIM protein; ZASP, Z-band alternatively
spliced PDZ motif protein; ENH, enigma ho-
molog; FATZ, filamin-, actinin-, and telethonin
binding protein of the Z disc; N-RAP, nublulin-
related anchoring protein; MURF-3, muscle-
specific RING-finger protein-3.
disc also anchors titin, a 2-3 MDa muscle-specific pro- fects on sarcomeric assembly (Xu et al., 2002). Knock-
outs of three genes encoding members of the muscle-tein. Titin contains two -actinin binding domains at its
restricted Z disc cytoskeletal LIM domain family (MLP,N terminus and spans the length of each half-sarcomere,
ALP, and Cypher, see Figure 3) result in distinct formsreaching the M line in the middle of A-band. T-cap, a
of right ventricular cardiomyopathy, neonatal cardiomy-19 kDa muscle-specific protein was isolated as a titin
opathy, and classical adult onset dilated cardiomyopa-binding protein at the Z disc. In cardiac myocytes, Z
thy, suggesting specific roles for these proteins at dis-disc proteins and other components of this cytoskeletal
crete stages of pre- and postnatal cardiac growth andprotein network play diverse roles in sarcomeric organi-
development (Arber et al., 1997; Pashmforoush et al.,zation, force transduction, and force transmission. Re-
2001; Zhou et al., 2001). The precise molecular mecha-cent studies indicate that there may be an additional
nisms that link defects in the Z disc or other cytoskeletalspecific role in biomechanical stretch responses and
protein mutations with the onset of DCM and the pro-associated downstream signaling events (K.R.C., UCSD).
gression of heart failure remain largely unknown. In thisIn addition, experimental studies in gene-targeted ani-
regard, genetic complementation studies in MLP defi-mal models and familial forms of the human disease are
cient mice have shown that the loss of Z disc proteinsbeginning to point to an important, previously unsus-
does not inherently lead to cardiac structural and func-pected role of the cardiac myocyte cytoskeleton in the
tional defects (Minamisawa et al., 1999), thereby indicat-pathogenesis of dilated cardiomyopathy (Chien, 2000;
ing that the disruption of sarcomeric assembly, forceSeidman and Seidman, 2001). It will be interesting to
generation, and sarcolemmal integrity in end-stagedetermine whether Z disc proteins also participate di-
DCM in this model system may reflect secondary, versusrectly in the localization of signaling molecules involved
primary effects of this class of cytoskeletal mutation.in transmission of mechanical signals, as suggested by
The generation of mice harboring a double knockout of
the localization of the PKC binding of the PDZ-LIM do-
MLP and the muscle specific inhibitor of sarcoplasmic
main protein Cypher (E. Zhou et al., 1999, 2001) and the reticulum (SR) Ca2ATPase, phospholamban, display
calcineurin binding protein, calsarcins (E. Olson), to the complete rescue from the onset of dilated cardiomyopa-
Z disk. thy and heart failure, while somatic gene transfer of a
The mechanistic pathways that link cytoskeletal de- phospholamban inhibitory peptide in the setting of
fects with cardiomyopathy and associated heart failure delta-sarcoglycan deficiency prevents the onset of end-
are currently unclear, but hints are being derived from stage heart failure (Hoshijima et al., 2002), pointing to a
experimental model systems. Studies of a mouse model critical role of SR calcium cycling in heart failure progres-
of the delta-sarcoglycan related cardiomyopathy now sion. The critical issue is whether these beneficial effects
suggest that the cardiac lesions appear secondary to of enhanced calcium cycling represent primary effects
a primary requirement in the coronary arterial smooth on Z disc proteins and DCM, or whether this reflects a
muscle, which develops chronic vasospasm, thereby non-cell-autonomous effect secondary to relieving wall
accounting for the focal, perivascular nature of the phe- stress. If there are distinct mechanistic pathways by
notype (E. McNally, University of Chicago). which each of these diverse cytoskeletal mutations lead
Mutations in titin have now been directly implicated to dilated cardiomyopathy, careful study of these dis-
in familial forms of dilated cardiomyopathy in humans ease pathways may offer an opportunity to identify the
(Gerull et al., 2002) and studies in a zebrafish model precise functions of these genes in the control of in vivo
cardiac myocyte function.system suggest that the defects most likely reflect ef-
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Figure 4. Developmental Pathways for the
Formation of the Cardiac Conduction System
The interzonal myocardial rings from the lin-
ear heart tube to the four chambered heart
correspond, in part, to components of the
specialized cardiac conduction system in-
cluding the SAN, AVN, and Bundle of His and
PF (rings and components of the conduction
system are color coded). Looping of the im-
mature heart tube brings these rings to their
approximate positions in the mature heart.
Normal electrophysiological function of the
heart depends on proper development of all
lineages within the cardiac conduction sys-
tem, as illustrated by the distinct electrophys-
iological profile of each individual compo-
nent. Disruption of any one of these
components is not lethal, but can lead to nu-
merous electrophysiological defects. A num-
ber of genes have been identified in various
components of the conduction system in-
cluding, but not exclusive to, connexin-40,
HF1b, nkx2.5, and tbx5. Mouse knockout
models for each of these genes have been
studied revealing numerous electrophysio-
logical defects related to abnormalities in var-
ious components of the conduction system. VKO: ventricular restricted knock out; SAN sinus node; A, atria; AVN, atrioventricular node; PF,
Purkinje fiber; V, ventricle; B, common bundle; BB, bundle branches; CHD, congenital heart defects; CM, cardiomyopathy; AVB, AV block;
SP, sinus pause; VT, ventricular tachycardia.
Conduction Lineages and Arrhythmogenesis and genomic databases could eventually be instructive
in identifying these molecular pathways.The orderly propagation of cardiac electrical impulses is
mediated by a spatially restricted network of specialized Defects in the developmental pathways that control
conduction system formation have now been directlyconduction system cell lineages (Figure 4). Until re-
cently, the precise identification of these lineages, their implicated in cardiac sudden death and associated ar-
rhythmias in both experimental model systems and rareorigins, and their precise role in specific forms of cardiac
disease, have been a mystery. An important step for- forms of human diseases (Figure 4). Previous studies
in genetically engineered animal models suggest thatward was the demonstration that a major portion of
the conduction system cells in the ventricular chamber, defects in the transition between ventricular and con-
duction system cells (Purkinje cells) can lead to thePurkinje cells, were actually derived from myogenic pre-
cursors, indicating that these represent extensively anatomic substrate for sudden death, including de-
creased expression and mislocalization of the conduc-modified cardiac myocytes that acquire specialized
electrophysiological properties of spontaneous pace- tion system-restricted marker, connexin 40 (Nguyen-
Tran et al., 2000). HF1b, a member of the SP-1 familymaker function and other distinct regulatory pathways
that are not shared with their neighboring ventricular of transcription factors, displays a restricted pattern of
expression in conduction system lineages, and HF1b/muscle cell lineages (for review, see Gourdie et al., 1999).
Elegant studies by Glenn Fishman (NYU) have led to the mice display normal cardiac structure and contractile
function, but display defects in Purkinje fiber formation,development of a mouse model that expresses LacZ
selectively in the cardiac conduction system in the heart manifested as a confused electrophysiological identity
in Purkinje and ventricular cell lineages, resulting in car-(Rentschler et al., 2001). This mouse has allowed a de-
tailed view of the maturing conductive system network diac sudden death and marked tachy and brady arrhyth-
mias. Since HF1b is expressed in ventricular myocar-and together with optical mapping studies correlating
morphology of the conduction system with functionality, dium as well as the neural tube, which gives rise to
the neural crest, the question arises as to where thethese studies provide a basis for understanding the reg-
ulatory circuitry guiding conduction system specializa- requirement for HF1b is located with respect to the de-
fects in conduction system lineages. Neural crest lin-tion (see Figure 4). Utilizing this model, a direct role for
neuregulin pathways in triggering the formation of the eages are important for the formation of the autonomic
nervous system that innervates the AV node, and alsoconduction system has been found (Rentschler et al.,
2002), which may represent one of the subendocardial are critical for the formation of the coronary arterial sys-
tem, which has been shown to generate cues for Pur-cues that has been suspected to contribute to this tran-
sition. Since each of the components of the conduction kinje fiber formation. As a number of neural-restricted
genes are expressed within conduction system lin-system has distinct electrophysiological properties (SA
node, AV node, His bundle, Purkinje; see Figure 4), there eages, it will become of interest to define more precisely
the contribution of neural crest lineages to conductionmust be additional factors that lead to the formation of
specific conduction system lineages. New models that system development (K.R.C., UCSD).
Recent studies of patients with familial forms of con-will allow the sorting of conduction system cell lineages,
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genital heart disease also support the concept that de- tion, studies by two independent groups also support
a negligible level of transduction of host cells to cardiacfects in transcriptional factors can lead to cardiac ar-
rhythmogenesis via effects on both ventricular and myocytes in transplanted human hearts (C. Murry, J.
Epstein) (Glaser et al., 2002). While the hope remainsconduction system lineages. Patients that harbor muta-
tions in the transcription factor TBX-5 display large atrial that cardiac homing of circulating hematopoietic stem
cells might participate in repair of the injured myocar-septal defects and a wide spectrum of other cardiac
malformations that can be associated with severe con- dium, it is also apparent that the endogenous repair
process is inadequate to improve cardiac function fol-duction defects (Bruneau et al., 2001). The question has
arisen as to whether the conduction system defects are lowing damage. Thus, future efforts should be directed
toward the identification of signals involved in attraction,simply secondary to the structural defects in the heart
and associated distortion of conduction system devel- proliferation, and cardiogenic conversion of circulating
stem cells.opment. Recent studies in TBX-5-deficient mice support
the concept that TBX-5 may have dual effects on the One of the fundamental differences between cardiac
and skeletal muscle is that skeletal muscle is able todisruption of the normal spatial configuration of the de-
veloping conduction system, as well as cell-autono- regenerate in response to damage by the awakening of
quiescent precursor cells, known as satellite cells, whichmous effects on conduction lineages, as TBX5 appears
to be a direct transcriptional regulator of the Connexin- lie between the basal lamina and the muscle fiber. Car-
diac satellite cells have not been identified, and if they40 gene (C. Seidman, Harvard). Recent clinical studies
have also shown that mutations in the cardiac transcrip- do exist, must be present in amounts too low for efficient
cardiac repair. Others have reported the presence oftion factor Nkx-2.5 can lead to cardiac congenital heart
defects that are accompanied by arrhythmogenesis, stem cells in skeletal muscle that can be coaxed into
cardiac lineages in the in vitro context (N. Epstein,complete heart block, and sudden death (Schott et al.,
1998) (Kasahara et al., 2000). Conventional Nkx-2.5 NHLBI), suggesting that indeed there may be merit in
studying the pathways that lead to the renewal andknockout mice that harbor a complete ablation of the
Nkx-2.5 gene display early embryonic lethality and car- recruitment of muscle stem cells into cardiac lineages in
the in vivo context. The nature of the paracrine pathwaysdiac looping defects, consistent with the known role of
this cardiac homeobox gene in the earliest stages of that might enhance these steps in stem cell commitment
is largely unknown, but a recent report suggests thatcardiogenesis (Lyons et al., 1995). It will become of inter-
est to determine if this association with NKX2.5 and IGF-1 might serve as a priming stimulus to recruit and
commit circulating stem cells to the myogenic lineage incardiac arrhythmias represents a direct effect on con-
duction system cell lineages, thereby reflecting an addi- damaged or degenerating muscle (N. Rosenthal, EMBL),
suggesting that there might be a similar effect for cardiactional role for this homeobox gene at later stages of
cardiac maturation, including the postnatal myocardium lineages as well. Establishing high throughput assay
systems that eventually will allow the expression cloning(K.R.C., UCSD). The list of genetic pathways for cardiac
arrythmogenesis that arise from developmental defects and/or biochemical identification of the external factors
and cues required for cardiac stem cell renewal andin conduction system lineages is likely to grow as the
pathways that control conduction system development recruitment should now be possible. Microarray and
bioinformatics approaches to identify possible cyto-continue to be unraveled by multiple laboratories.
kines and other extracellular factors involved in stem cell
attraction and propagation in the heart also representStem Cell Lineages and CV Disease
potentially powerful approaches to this problem. Cur-The major causes of heart failure are related to the onset
rently, the realistic prospects for stem cell therapy forof cardiac injury by a variety of pathological stimuli,
cardiac repair appear to be distant, based on the needparticularly after the irreversible damage that arises from
to purify and to deliver in vivo a sufficient quantity ofmyocardial infarction. The longstanding axiom has been
the cells to improve global cardiac function, and thethat the myocardium has a limited capacity for self repair
potential for electrophysiological heterogeneity thator regeneration, and the irreversible loss of muscle sets
could represent the substrate for arrhythmogenesis. Ainto play a series of events that ultimately leads to in-
longer term, but perhaps more feasible strategy wouldcreased wall stress, chamber dilation, and progressive
be to identify the factors required for self renewal andheart failure. The loss of myocyte survival cues is associ-
recruitment of cardiac stem cells into the injured myo-ated with diverse pathways for heart failure (Chien,
cardium.1999), underscoring the importance of maintaining the
number of viable heart muscle cells during heart failure
progression. This axiom has recently been challenged Future Perspectives
As witnessed by CV@CSH, a new interdisciplinary ap-by the discovery that bone-marrow-derived stem cells
can be transduced into cardiac myocyte lineages follow- proach to cardiovascular biology is underway, with the
traditional boundaries between the fields for cardiovas-ing their in vivo injection into the scar of post-infarcted
hearts (Orlic et al., 2001). A recent report (Murry, Univer- cular development and disease rapidly vanishing. Given
the current arsenal of post-genome technology, data-sity of Washington) at this meeting now suggests that
the ability of such stem cells to effectively improve long- bases, and multiple model organisms, there has never
been a more opportune time to tackle complex ques-term cardiac function may be more limited than initially
reported. Studies employing LacZ-marked hematopoi- tions in integrative physiology in general, and cardiovas-
cular physiology in particular. Higher throughput physio-etic stem cells have provided little evidence of the regen-
eration of the infarcted mouse heart (C. Murry). In addi- logical assay systems and computational biology are
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Frey, N., McKinsey, T.A., and Olson, E.N. (2000). Decoding calciumlikely to play increasingly important roles. Insights from
signals involved in cardiac growth and function. Nat. Med. 6, 1221–human population studies are on the horizon, but will
1227.require large numbers, longitudinal follow-up, and vali-
Gerull, B., Gramlich, M., Atherton, J., McNabb, M., Trombitas, K.,dation in experimental model systems to move beyond
Sasse-Klaassen, S., Seidman, J.G., Seidman, C., Granzier, H., La-
association studies and toward mechanistic disease beit, S., et al. (2002). Mutations of TTN, encoding the giant muscle
pathways. In an era when complex human biology is filament titin, cause familial dilated cardiomyopathy. Nat. Genet. 30,
the object of our desire, the CV system has the inherent 201–204.
advantage that the in vivo integrated functional end- Glaser, R., Lu, M.M., Narula, N., and Epstein, J.A. (2002). Smooth
muscle cells, but not myocytes, of host origin in transplanted humanpoints are readily quantifiable, largely conserved across
hearts. Circulation 106, 17–19.species, and can be directly linked to human biology and
Gourdie, R.G., Kubalak, S., and Mikawa, T. (1999). Conducting thedisease. Given the growing burden of cardiovascular
embryonic heart: orchestrating development of specialized cardiacdisease world-wide and the opportunities presented by
tissues. Trends Cardiovasc. Med. 9, 18–26.the numerous in vivo quantitative endpoints in the CV
Hoshijima, M., and Chien, K.R. (2002). Mixed signals in heart failure:system, a renaissance in integrative physiology may be
cancer rules. J. Clin. Invest. 109, 849–855.in the offing. In the post genome era, the heart is well-
Hoshijima, M., Ikeda, Y., Iwanaga, Y., Minimisawa, S., Li, X., Yusu,positioned to move from being simply a disease-based
G., Wang, L., Wilson, J., Wang, Y., Ross, J.J., and Chien, K.R. (2002).
area of inquiry to a model for understanding complex Chronic Inhibition of Heart Failure Progression by a pseudophos-
human biology and systems at an integrated molecular phorylated Mutant of Phospholamban via Cardiac rAAV Gene Deliv-
level. To accomplish this task, it may be necessary to ery. Nat. Med. 8, 864–871.
forge global CV integrative biology networks. In short, Jacob, H.J., and Kwitek, A.E. (2002). Rat genetics: attaching physiol-
ogy and pharmacology to the genome. Nat. Rev. Genet. 3, 33–42.cross strait relations have never looked more auspi-
cious. “One country-one system” appears to be the evo- Jerome, L.A., and Papaioannou, V.E. (2001). DiGeorge syndrome
phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet.lutionary path ahead for the field.
27, 286–291.
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